Marker Therapeutics, Inc. (MRKR)
1.33
-0.04
(-2.92%)
USD |
NASDAQ |
Aug 31, 16:00
1.33
0.00 (0.00%)
After-Hours: 20:00
Marker Therapeutics Cash from Operations (TTM) : -9.756M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.756M |
| March 31, 2026 | -7.918M |
| December 31, 2025 | -12.01M |
| September 30, 2025 | -14.82M |
| June 30, 2025 | -10.88M |
| March 31, 2025 | -12.57M |
| December 31, 2024 | -10.91M |
| September 30, 2024 | -8.575M |
| June 30, 2024 | -10.90M |
| March 31, 2024 | -14.39M |
| December 31, 2023 | -16.44M |
| September 30, 2023 | -20.38M |
| June 30, 2023 | -26.90M |
| March 31, 2023 | -20.63M |
| December 31, 2022 | -26.97M |
| September 30, 2022 | -25.52M |
| June 30, 2022 | -24.39M |
| March 31, 2022 | -30.51M |
| December 31, 2021 | -27.28M |
| September 30, 2021 | -28.64M |
| June 30, 2021 | -26.36M |
| March 31, 2021 | -23.81M |
| December 31, 2020 | -18.86M |
| September 30, 2020 | -17.20M |
| June 30, 2020 | -18.63M |
| Date | Value |
|---|---|
| March 31, 2020 | -18.45M |
| December 31, 2019 | -18.28M |
| September 30, 2019 | -19.89M |
| June 30, 2019 | -17.79M |
| March 31, 2019 | -16.01M |
| December 31, 2018 | -14.48M |
| September 30, 2018 | -10.80M |
| June 30, 2018 | -9.249M |
| March 31, 2018 | -8.862M |
| December 31, 2017 | -8.439M |
| September 30, 2017 | -7.715M |
| June 30, 2017 | -7.662M |
| March 31, 2017 | -7.604M |
| December 31, 2016 | -6.510M |
| September 30, 2016 | -5.607M |
| June 30, 2016 | -5.300M |
| March 31, 2016 | -4.159M |
| December 31, 2015 | -4.343M |
| September 30, 2015 | -4.162M |
| June 30, 2015 | -3.403M |
| March 31, 2015 | -2.828M |
| December 31, 2014 | -2.187M |
| September 30, 2014 | -1.534M |
| June 30, 2014 | -0.7628M |
| March 31, 2014 | -0.6731M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Krystal Biotech, Inc. | 272.34M |
| Ironwood Pharmaceuticals, Inc. | 185.56M |
| SELLAS Life Sciences Group, Inc. | -28.42M |
| Rezolute, Inc. | -73.48M |
| ADMA Biologics, Inc. | 136.72M |